Automation Anywhere launches EnterpriseClaw with Cisco, NVIDIA, Okta, OpenAI

Automation Anywhere announced EnterpriseClaw, a capability developed with Cisco (NASDAQ: CSCO), NVIDIA (NASDAQ: NVDA), Okta (NASDAQ: OKTA), and OpenAI to deploy AI agents across enterprise systems. The platform enables organizations to run autonomous AI agents across cloud platforms, desktops, on-premises systems, and secured enterprise networks.

EnterpriseClaw integrates with enterprise technology providers through specific collaborations. Cisco AI Defense and DefenseClaw provide security features for agents. NVIDIA contributes OpenShell, an open-source runtime for autonomous agents, along with NIM microservices and Nemotron models for on-premises customers. Okta delivers identity management and authentication controls, while OpenAI enables companies to build agents using OpenAI models including GPT-5.5.

"For AI to have a transformational impact on business, it needs to be able to do work where the work actually happens," said Mihir Shukla, CEO and Board Chairman of Automation Anywhere. The platform addresses enterprise operations that span teams, cloud platforms, desktops, on-premises systems, and regulated infrastructure.

The system incorporates Automation Anywhere's Process Reasoning Engine and Contextual Intelligence Graph to provide enhanced accuracy and process context for business-critical automation tasks. Organizations can use the platform to investigate complex customer claims by gathering information across desktop applications, on-premises systems, internal documents, and cloud platforms while keeping sensitive data within secured enterprise systems.

EnterpriseClaw is designed to be extensible across AI agent frameworks, allowing organizations to deploy internally developed agents or those built using third-party tools alongside existing automations. The platform is available in preview, with general availability expected later this year.

You May Also Be Interested In

• Roku Said To Be In Sale Talks, Including Possible Media Tie-up - Bloomberg
• In memo, Meta says it plans to crack down on employee token use as AI costs soar - The Information
• Lyell Immunopharma reports safety data for lymphoma CAR T-cell therapy